Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Tammie Kelsey"'
Autor:
Sam Frank, Michele Goldstein, Tammie Kelsey, Merit Cudkowicz, Kimberly L. Ferrante, Elisabeth A. de Blieck, Joseph Weber, Linda Metakis, Bernard Ravina, Ira Shoulson, Robert J. Ferrante, Karl Kieburtz, Danna Jennings, Francis O. Walker, Arthur Watts, Peter Como, Michael P. McDermott, Vicki Hunt, H. Christopher Hyson, Carol Zimmerman, Susan E. Browne, Susan Daigneault, M. Flint Beal, Kristyn Newhall
Publikováno v:
Movement Disorders. 25:1924-1928
Coenzyme Q10 (CoQ(10)), a potential neuroprotective compound, was previously investigated at a dosage of 600 mg/day in Huntington's disease (HD) patients and demonstrated a trend toward slowing disease progression. Higher CoQ(10) dosages may prove be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57941278e1c9c8de99960544f058b2a4
https://doi.org/10.1002/mds.22408
https://doi.org/10.1002/mds.22408
Autor:
H Christopher, Hyson, Karl, Kieburtz, Ira, Shoulson, Michael, McDermott, Bernard, Ravina, Elisabeth A, de Blieck, Merit E, Cudkowicz, Robert J, Ferrante, Peter, Como, Sam, Frank, Carol, Zimmerman, Kimberly, Ferrante, Kristyn, Newhall, Danna, Jennings, Tammie, Kelsey, Francis, Walker, Vicki, Hunt, Susan, Daigneault, Michele, Goldstein, Joseph, Weber, Arthur, Watts, M Flint, Beal, Susan E, Browne, Linda J, Metakis
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society. 25(12)
Coenzyme Q10 (CoQ(10)), a potential neuroprotective compound, was previously investigated at a dosage of 600 mg/day in Huntington's disease (HD) patients and demonstrated a trend toward slowing disease progression. Higher CoQ(10) dosages may prove be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::132468d80c70a2558f024c43eb71626b
https://pubmed.ncbi.nlm.nih.gov/20669312
https://pubmed.ncbi.nlm.nih.gov/20669312